From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry is growing rapidly and reached nearly 30,000 jobs spanning 2,160 business establishments in 2018. Industry employment has grown by 15 percent since 2016—twice the growth rate of the nation—with each of the five major subsectors adding jobs during the period. Arizona’s universities conducted nearly $580 million in R&D activities in bioscience-related fields in 2018, fueled in part by steadily increasing NIH awards to Arizona institutions since 2016. Venture capital investments in Arizona bioscience companies increased in 2019, and during the 2016-19 period totaled $349 million. Arizona inventors have been awarded 2,178 bioscience-related patents since 2016, among the second quintile of states in patent activity.
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
The UA is the lead institution for the Regional Algal Feedstock Testbed, or RAFT, partnership, which was recently awarded $8 million over four years by the Department of Energy to research how algae can be grown year-round outdoors in open ponds in different climates.
Ventana launches first fully automated IHC test to detect BRAF V600E mutation in a variety of cancers
Exclusive license agreement paves the way for industry’s first BRAF V600E IHC test
Gilbert Facility Is First of Its Kind With Contracts in Place to Deliver Products to Key Markets
Study with Geisinger Health System tests nearly 2,300 extremely obese diabetes patients
- Women’s Health Moves Mainstream – Rapid Growth Meets Underserved Market
- STEM Summit 2020
- The MedTech Conference
- 10/05/2020 - 10/07/2020
- Arizona Wellbeing Commons 2020
- AZBioPEERS: Leveraging the contacts you made during AZBW